CME Group (NASDAQ:CME) PT Raised to $216.00 at Bank of America

CME Group (NASDAQ:CMEGet Free Report) had its price objective boosted by stock analysts at Bank of America from $209.00 to $216.00 in a report issued on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the financial services provider’s stock. Bank of America‘s target price indicates a potential upside of 2.40% from the company’s previous close.

CME has been the subject of several other research reports. The Goldman Sachs Group cut CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a research note on Wednesday, January 3rd. Argus raised their price objective on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research report on Wednesday, March 6th. Rosenblatt Securities restated a “sell” rating and set a $187.00 target price (up previously from $185.00) on shares of CME Group in a research report on Thursday. Keefe, Bruyette & Woods raised their target price on CME Group from $222.00 to $226.00 and gave the stock a “market perform” rating in a research report on Thursday. Finally, Barclays lifted their price objective on CME Group from $225.00 to $226.00 and gave the company an “equal weight” rating in a research report on Monday, April 8th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and an average price target of $217.80.

Read Our Latest Stock Analysis on CME Group

CME Group Price Performance

CME stock opened at $210.94 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group has a 52-week low of $175.73 and a 52-week high of $223.80. The stock’s 50 day moving average is $214.73 and its two-hundred day moving average is $211.90. The company has a market capitalization of $75.94 billion, a PE ratio of 24.00, a P/E/G ratio of 5.97 and a beta of 0.49.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share for the quarter, beating analysts’ consensus estimates of $2.44 by $0.06. CME Group had a return on equity of 12.45% and a net margin of 56.84%. The business had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.48 billion. During the same period in the previous year, the business earned $2.42 EPS. The business’s quarterly revenue was up 3.2% on a year-over-year basis. Analysts predict that CME Group will post 9.58 earnings per share for the current fiscal year.

Hedge Funds Weigh In On CME Group

A number of institutional investors and hedge funds have recently made changes to their positions in CME. Naples Global Advisors LLC grew its holdings in CME Group by 5.6% during the 4th quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock valued at $436,000 after purchasing an additional 110 shares during the last quarter. Sapient Capital LLC acquired a new position in CME Group during the 4th quarter valued at approximately $1,823,000. FNY Investment Advisers LLC purchased a new stake in CME Group during the fourth quarter worth $1,074,000. Deutsche Bank AG lifted its stake in shares of CME Group by 4.3% in the third quarter. Deutsche Bank AG now owns 1,118,104 shares of the financial services provider’s stock worth $223,867,000 after buying an additional 46,021 shares in the last quarter. Finally, International Assets Investment Management LLC acquired a new stake in shares of CME Group during the fourth quarter valued at about $27,986,000. Institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.